Diamyd Medical AB (publ) (DMYD-B.ST)
SEK 10.1
(9.66%)
SEK 10.1
(9.66%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 24.05 Million SEK | -100.0% |
| 2023 | 1.00 SEK | 100.0% |
| 2022 | -2.47 Million SEK | -247900100.0% |
| 2021 | 1.00 SEK | -100.0% |
| 2020 | 353 Thousand SEK | 35299900.0% |
| 2019 | 1.00 SEK | 100.0% |
| 2018 | -732 Thousand SEK | -73200100.0% |
| 2017 | 1.00 SEK | 100.0% |
| 2016 | -637 Thousand SEK | -225.0% |
| 2015 | -196 Thousand SEK | -19600100.0% |
| 2014 | 1.00 SEK | 0.0% |
| 2013 | - SEK | -100.0% |
| 2012 | 5000.00 SEK | 0.0% |
| 2011 | 5000.00 SEK | -70.59% |
| 2010 | 17 Thousand SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | - SEK | 0.0% |
| 2024 Q4 | 24.05 Million SEK | 0.0% |
| 2024 Q1 | 16.71 Million SEK | 1671199900.0% |
| 2024 Q2 | - SEK | -100.0% |
| 2023 Q1 | 1.00 SEK | 100.0% |
| 2023 Q4 | 1.00 SEK | 0.0% |
| 2023 Q3 | 1.00 SEK | 0.0% |
| 2023 FY | 1.00 SEK | 100.0% |
| 2023 Q2 | 1.00 SEK | 0.0% |
| 2022 Q2 | 6.21 Million SEK | 0.0% |
| 2022 Q4 | -2.47 Million SEK | -247900100.0% |
| 2022 Q1 | - SEK | -100.0% |
| 2022 FY | -2.47 Million SEK | -247900100.0% |
| 2022 Q3 | 1.00 SEK | -100.0% |
| 2021 Q3 | 1.00 SEK | 0.0% |
| 2021 Q2 | 1.00 SEK | 100.0% |
| 2021 Q4 | 1.00 SEK | 0.0% |
| 2021 Q1 | -93 Thousand SEK | -102.35% |
| 2021 FY | 1.00 SEK | -100.0% |
| 2020 Q1 | 1.00 SEK | 0.0% |
| 2020 FY | 353 Thousand SEK | 35299900.0% |
| 2020 Q2 | 1.91 Million SEK | 191199900.0% |
| 2020 Q3 | - SEK | -100.0% |
| 2020 Q4 | 3.95 Million SEK | 0.0% |
| 2019 Q2 | 1.00 SEK | -100.0% |
| 2019 FY | 1.00 SEK | 100.0% |
| 2019 Q4 | 1.00 SEK | 0.0% |
| 2019 Q3 | 1.00 SEK | 0.0% |
| 2019 Q1 | 5.76 Million SEK | 5437.04% |
| 2018 Q2 | -19 Thousand SEK | -1900100.0% |
| 2018 Q4 | -108 Thousand SEK | -10800100.0% |
| 2018 Q3 | 1.00 SEK | 100.01% |
| 2018 Q1 | 1.00 SEK | 0.0% |
| 2018 FY | -732 Thousand SEK | -73200100.0% |
| 2017 Q3 | 1.00 SEK | -100.0% |
| 2017 Q2 | 1.09 Million SEK | -38.87% |
| 2017 Q4 | 1.00 SEK | 0.0% |
| 2017 FY | 1.00 SEK | 100.0% |
| 2017 Q1 | 1.78 Million SEK | 931.63% |
| 2016 Q1 | 1.00 SEK | 100.0% |
| 2016 FY | -637 Thousand SEK | -225.0% |
| 2016 Q3 | -188 Thousand SEK | -18800100.0% |
| 2016 Q4 | -215 Thousand SEK | -14.36% |
| 2016 Q2 | 1.00 SEK | 0.0% |
| 2015 Q1 | -44 Thousand SEK | -4400100.0% |
| 2015 FY | -196 Thousand SEK | -19600100.0% |
| 2015 Q3 | 1.00 SEK | -100.0% |
| 2015 Q4 | -196 Thousand SEK | -19600100.0% |
| 2015 Q2 | 819 Thousand SEK | 1961.36% |
| 2014 Q2 | 1.00 SEK | 100.0% |
| 2014 Q1 | -58 Thousand SEK | 0.0% |
| 2014 Q4 | 1.00 SEK | 100.0% |
| 2014 FY | 1.00 SEK | 0.0% |
| 2014 Q3 | -45 Thousand SEK | -4500100.0% |
| 2013 Q3 | 1.00 SEK | 0.0% |
| 2013 Q4 | - SEK | -100.0% |
| 2013 FY | - SEK | -100.0% |
| 2013 Q1 | - SEK | -100.0% |
| 2012 Q1 | 6000.00 SEK | 20.0% |
| 2012 FY | 5000.00 SEK | 0.0% |
| 2012 Q3 | 6000.00 SEK | 20.0% |
| 2012 Q2 | 5000.00 SEK | -16.67% |
| 2012 Q4 | 5000.00 SEK | -16.67% |
| 2011 Q2 | 15 Thousand SEK | 0.0% |
| 2011 FY | 5000.00 SEK | -70.59% |
| 2011 Q3 | 5000.00 SEK | -66.67% |
| 2011 Q4 | 5000.00 SEK | 0.0% |
| 2010 FY | 17 Thousand SEK | 0.0% |
| 2010 Q4 | 17 Thousand SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Active Biotech AB (publ) | -2500.00 SEK | 962100.0% |
| Biovica International AB (publ) | 2.19 Million SEK | -993.679% |
| Cantargia AB (publ) | - SEK | -Infinity% |
| CombiGene AB (publ) | -1.79 Million SEK | 1436.854% |
| Cyxone AB (publ) | - SEK | -Infinity% |
| Diagonal Bio AB (publ) | 1.02 Million SEK | -2239.494% |
| Elicera Therapeutics AB (publ) | -446.98 Thousand SEK | 5480.482% |
| ExpreS2ion Biotech Holding AB (publ) | - SEK | -Infinity% |
| Fluicell AB (publ) | 3.15 Million SEK | -663.492% |
| Infant Bacterial Therapeutics AB (publ) | - SEK | -Infinity% |
| Mendus AB (publ) | - SEK | -Infinity% |
| Isofol Medical AB (publ) | - SEK | -Infinity% |
| I-Tech AB | 4.28 Million SEK | -461.916% |
| Intervacc AB (publ) | 10.48 Million SEK | -129.419% |
| Lipigon Pharmaceuticals AB (publ) | -1.62 Million SEK | 1579.09% |
| Magle Chemoswed Holding AB (publ) | 35.22 Million SEK | 31.732% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| OncoZenge AB (publ) | -862.99 Thousand SEK | 2886.793% |
| Sprint Bioscience AB (publ) | -7.13 Million SEK | 437.024% |
| Xbrane Biopharma AB (publ) | 106.85 Million SEK | 77.493% |
| Lipum AB (publ) | - SEK | -Infinity% |
| Alligator Bioscience AB (publ) | 2.00 SEK | -1202499900.0% |
| Ziccum AB (publ) | -4.18 Million SEK | 674.123% |
| BioArctic AB (publ) | - SEK | -Infinity% |
| Genovis AB (publ.) | 14.9 Million SEK | -61.355% |
| Camurus AB (publ) | 100.95 Million SEK | 76.178% |
| IRLAB Therapeutics AB (publ) | 1000.00 SEK | -2404900.0% |
| Bio-Works Technologies AB (publ) | 9.06 Million SEK | -165.218% |
| Aptahem AB (publ) | - SEK | -Infinity% |
| Vicore Pharma Holding AB (publ) | - SEK | -Infinity% |
| Xspray Pharma AB (publ) | 43.78 Million SEK | 45.067% |
| Kancera AB (publ) | -1950.00 SEK | 1233433.333% |
| Saniona AB (publ) | 1.00 SEK | -2404999900.0% |
| Spago Nanomedical AB (publ) | 1.00 SEK | -2404999900.0% |
| AcouSort AB (publ) | 2.08 Million SEK | -1056.25% |
| Xintela AB (publ) | 398 Thousand SEK | -5942.714% |
| Abliva AB (publ) | - SEK | -Infinity% |
| Karolinska Development AB (publ) | - SEK | -Infinity% |
| Amniotics AB (publ) | 534 Thousand SEK | -4403.745% |
| 2cureX AB (publ) | -1000.00 SEK | 2405100.0% |
| Asarina Pharma AB (publ) | - SEK | -Infinity% |
| Calliditas Therapeutics AB (publ) | 20.42 Million SEK | -17.731% |
| Hansa Biopharma AB (publ) | 9.79 Million SEK | -145.609% |
| Biosergen AB | -4.92 Million SEK | 587.929% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | - SEK | -Infinity% |
| Corline Biomedical AB | -3.85 Million SEK | 723.542% |
| NextCell Pharma AB | 545.23 Thousand SEK | -4310.926% |
| Nanologica AB (publ) | 2.97 Million SEK | -708.947% |
| LIDDS AB (publ) | - SEK | -Infinity% |
| Egetis Therapeutics AB (publ) | 700 Thousand SEK | -3335.714% |
| BioInvent International AB (publ) | 11.84 Million SEK | -103.056% |
| SynAct Pharma AB | - SEK | -Infinity% |
| Annexin Pharmaceuticals AB (publ) | - SEK | -Infinity% |
| Stayble Therapeutics AB (publ) | -321.14 Thousand SEK | 7588.829% |
| Alzinova AB (publ) | -3.27 Million SEK | 833.679% |
| Ascelia Pharma AB (publ) | - SEK | -Infinity% |
| Oncopeptides AB (publ) | 2.42 Million SEK | -891.753% |
| Pila Pharma AB (publ) | 1.00 SEK | -2404999900.0% |
| Guard Therapeutics International AB (publ) | -1486.00 SEK | 1618538.762% |
| Scandinavian ChemoTech AB (publ) | 4.03 Million SEK | -496.182% |
| Simris Alg AB (publ) | 1.09 Million SEK | -2104.4% |